Acadian Asset Management
TNXP icon

Acadian Asset Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Acadian Asset Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-578
Closed -$39K – 2338
2024
Q2 		$39K Buy
578
+473
+450% +$215K ﹤0.01% 1626
2024
Q1 		$61K Buy
105
+76
+262% +$81.9K ﹤0.01% 1359
2023
Q4 		$37K Buy
29
+24
+480% +$38.6K ﹤0.01% 1497
2023
Q3 		$8K Sell
5
-16
-76% -$58.5K ﹤0.01% 1604
2023
Q2 		$108K Buy
21
+13
+163% +$98.5K ﹤0.01% 1393
2023
Q1 		$94K Sell
8
-37
-82% -$635K ﹤0.01% 1402
2022
Q4 		$349K Buy
+45
New +$388K ﹤0.01% 1137
2022
Q3 		– Sell
-23
Closed -$712K – 1850
2022
Q2 		$712K Buy
+23
New +$1.7M ﹤0.01% 890
2020
Q1 		– Hold
0
– -$46K – 1942
2019
Q4 		– Hold
0
– – – 1614
2019
Q3 		– Hold
0
– – – 1688
2019
Q2 		– Hold
0
– – – 1386
2019
Q1 		– Hold
0
– – – 1809
2018
Q4 		– Hold
0
– -$4K – 1834
2018
Q3 		– Hold
0
– – – 1629
2018
Q2 		– Hold
0
– -$53K – 1840
2018
Q1 		– Hold
0
– – – 1345
2017
Q4 		– Hold
0
– – – 1232

Other funds holding TNXP

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Personalized Indexing Management
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

Acadian Asset Management's TNXP Position: Q3 2024 in Review

Acadian Asset Management sold out of Tonix Pharmaceuticals (TNXP) in Q3 2024, closing a stake of 578 shares — an estimated $39K sold.

Acadian Asset Management first reported a position in TNXP in Q2 2022 and held it in 8 quarters. The position peaked at $712K in Q2 2022. 16 funds tracked by Wall St. Rank hold TNXP as of Q3 2024.

  • Acadian Asset Management reported no remaining Tonix Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Acadian Asset Management sold 578 Tonix Pharmaceuticals shares in Q3 2024, an estimated $39K.
  • Acadian Asset Management first reported a position in Tonix Pharmaceuticals in Q2 2022 and held it in 8 quarters.
  • Acadian Asset Management's Tonix Pharmaceuticals position peaked at $712K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2024.

Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.